Meeting of the Advisory Committee on Training and Primary Care Medicine and Dentistry, 42476-42477 [2024-10614]
Download as PDF
<![CDATA[
42476
Federal Register / Vol. 89, No. 95 / Wednesday, May 15, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
FDA sent Ms. Acosta, by certified
mail, on January 30, 2024, a notice
proposing to permanently debar her
from providing services in any capacity
to a person that has an approved or
pending drug product application. The
proposal was based on a finding, under
section 306(a)(2)(B) of the FD&C Act,
that Ms. Acosta was convicted of a
felony under Federal law for conduct
relating to the regulation of a drug
product under the FD&C Act. The
proposal informed Ms. Acosta of the
proposed debarment and offered her an
opportunity to request a hearing,
providing her 30 days from the date of
receipt of the letter in which to file the
request, and advised her that failure to
request a hearing constituted a waiver of
the opportunity for a hearing and of any
contentions concerning this action. Ms.
Acosta received the proposal and notice
of opportunity for a hearing on February
5, 2024. Ms. Acosta failed to request a
hearing within the timeframe prescribed
by regulation and has, therefore, waived
her opportunity for a hearing and
waived any contentions concerning her
debarment (21 CFR part 12).
II. Findings and Order
Therefore, the Assistant
Commissioner, Office of Human and
Animal Food Operations, under section
306(a)(2)(B) of the FD&C Act, under
authority delegated to the Assistant
Commissioner, finds that Ms. Gina
Acosta has been convicted of a felony
under Federal law for conduct relating
to the regulation of a drug product
under the FD&C Act.
As a result of the foregoing finding,
Ms. Acosta is permanently debarred
from providing services in any capacity
to a person with an approved or
pending drug product application,
effective (see DATES) (see sections
306(a)(2)(B) and 306(c)(2)(A)(ii) of the
FD&C Act). Any person with an
approved or pending drug product
application who knowingly employs or
retains as a consultant or contractor, or
otherwise uses in any capacity the
services of Ms. Acosta during her
debarment, will be subject to civil
money penalties (section 307(a)(6) of the
FD&C Act (21 U.S.C. 335b(a)(6))). If Ms.
Acosta provides services in any capacity
to a person with an approved or
pending drug product application
during her period of debarment, she will
be subject to civil money penalties
(section 307(a)(7) of the FD&C Act). In
addition, FDA will not accept or review
any abbreviated new drug application
from Ms. Acosta during her period of
debarment, other than in connection
with an audit under section 306 of the
FD&C Act (section 306(c)(1)(B) of the
VerDate Sep<11>2014
19:12 May 14, 2024
Jkt 262001
FD&C Act). Note that, for purposes of
sections 306 and 307 of the FD&C Act,
a ‘‘drug product’’ is defined as a ‘‘drug
subject to regulation under section 505,
512, or 802 of the FD&C Act (21 U.S.C.
355, 360b, or 382) or under section 351
of the Public Health Service Act (42
U.S.C. 262)’’ (section 201(dd) of the
FD&C Act (21 U.S.C. 321(dd))).
Dated: May 8, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–10584 Filed 5–14–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Training and Primary Care Medicine
and Dentistry
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Training in Primary Care
Medicine and Dentistry (ACTPCMD or
Committee) will hold public meetings
for the 2024 calendar year (CY). This
notice supersedes the information about
ACTPCMD’s 2024 meetings found in the
Federal Register notice dated December
15, 2023, Meeting of the Advisory
Committee on Training and Primary
Care Medicine and Dentistry.
DATES: ACTPCMD meetings will be held
on:
• August 1, 2024, 8:00 a.m.–5:00 p.m.
Eastern Time and August 2, 2024, 8:00
a.m.–3:00 p.m. Eastern Time, and
• Another 2024 meeting will be
identified at a later date and announced
at least 30 days before the meeting date
through the Federal Register.
ADDRESSES: Meetings will be held inperson, by teleconference, and/or on a
video conference platform. In-person
meetings will be held at the HRSA
Headquarters located at 5600 Fishers
Lane, Rockville, Maryland, 20857 and
will also be broadcast virtually on a
video conference platform. For updates
on how the meetings will be held, visit
the ACTPCMD website 20 days before
the date of the meeting, where
instructions for joining meetings will be
posted. For meeting information
updates, go to the ACTPCMD website
meeting page at https://www.hrsa.gov/
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
advisory-committees/primarycaredentist/meetings.
FOR FURTHER INFORMATION CONTACT:
Shane Rogers, Designated Federal
Officer, Division of Medicine and
Dentistry, Bureau of Health Workforce,
HRSA, 5600 Fishers Lane, Room
15N102, Rockville, Maryland 20857;
301–443–5260; or SRogers@hrsa.gov.
SUPPLEMENTARY INFORMATION:
ACTPCMD provides advice and
recommendations to the Secretary of
Health and Human Services on policy,
program development, and other
matters of significance concerning the
activities under Section 747 of Title VII
of the Public Health Service (PHS) Act,
as it existed upon the enactment of
Section 749 of the PHS Act in 1998.
ACTPCMD prepares an annual report
describing the activities of the
committee, including findings and
recommendations made by the
committee concerning the activities
under Section 747, as well as training
programs in oral health and dentistry.
The annual report is submitted to the
Secretary of Health and Human Services
as well as the Chair and ranking
members of the Senate Committee on
Health, Education, Labor and Pensions
and the House of Representatives
Committee on Energy and Commerce.
ACTPCMD also develops, publishes,
and implements performance measures
and guidelines for longitudinal
evaluations of programs authorized
under title VII, part C of the PHS Act,
and recommends appropriation levels
for programs under this Part.
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
For CY 2024 meetings, agenda items
may include, but are not limited to, a
full review of the many programs
authorized under title VII, sections 747
and 748, of the PHS Act, discussions
pertaining to tribal health issues, and
potential recommendations updating
the authorizing legislations for the
programs. Refer to the ACTPCMD
website listed above for all current and
updated information concerning the CY
2024 ACTPCMD meetings, including
agendas and meeting materials that will
be posted 20 calendar days before the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to ACTPCMD
should be sent to Shane Rogers using
E:\FR\FM\15MYN1.SGM
15MYN1
42477
Federal Register / Vol. 89, No. 95 / Wednesday, May 15, 2024 / Notices
the contact information above at least 5
business days before the meeting
date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Shane
Rogers using the contact information
listed above at least 10 business days
before the meeting(s) they wish to
attend. Since all in-person meetings will
occur in a federal government building,
5600 Fishers Lane, Rockville, Maryland
20857, attendees must go through a
security check to enter the building.
Members of the public must notify the
Designated Federal Officer of their
intent to attend the in-person meeting
10 business days before the meeting.
Non-U.S. Citizen attendees must notify
the Designated Federal Officer of their
planned attendance at least 20 business
days prior to the meeting to facilitate
their entry into the building. All
attendees are required to present
government-issued identification prior
to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–10614 Filed 5–14–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: 0937–0191–60D]
Agency Information Collection
Request; 60-Day Public Comment
Request
AGENCY:
Office of the Secretary, HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment. The ICR
is for extending the use of the approved
information collection assigned OMB
control number 0937–0191, which
expires on June 30, 2024. Prior to
submitting the ICR to OMB, OS seeks
comments from the public regarding the
burden estimate, below, or any other
aspect of the ICR.
DATES: Comments on the ICR must be
received on or before July 15, 2024.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0937–0191–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
SUMMARY:
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Application Packets for Real Property
for Public Health Purposes
Type of Collection: Reinstatement,
with no change.
OMB No. 0937–0191.
Abstract: The Office of Assistant
Secretary for Administration, Program
Support Center, Federal Real Property
Assistance Program is requesting OMB
approval on a previously approved
information collection, 0937–0191. 40
U.S.C. 550 (the ‘‘Act’’), as amended,
provides authority to the Secretary of
Health and Human Services to convey
or lease surplus real property to States
and their political subdivisions and
instrumentalities, to tax-supported
institutions, and to nonprofit
institutions which (except for
institutions which lease property to
assist the homeless) have been held
exempt from taxation under Section
501(c)(3) of the 1954 Internal Revenue
Code, and 501(c)(19) for veterans
organizations, for public health and
homeless assistance purposes. Transfers
are made to transferees at little or no
cost.
Type of respondent: Responses are
dependent on when Federal surplus real
property is made available and is
desired by a respondent/applicant for
acquisition. Likely respondents include
State, local, or tribal units of
government or instrumentalities thereof,
and not-for-profit organizations.
ANNUALIZED BURDEN HOUR TABLE
Average
burden
per
response
Total
burden
hours
Respondents
(if necessary)
Applications for surplus Federal real
property.
Total ...........................................
...........................................................
10
1
200
2,000
...........................................................
10
1
200
2,000
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–10610 Filed 5–14–24; 8:45 am]
National Institutes of Health
BILLING CODE 4150–04–P
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Number of
responses
per
respondents
Forms
(if necessary)
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
19:12 May 14, 2024
Jkt 262001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Systems
Biology of Metabolic Signaling in Aging and
Neurodegeneration.
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 89, Number 95 (Wednesday, May 15, 2024)]
[Notices]
[Pages 42476-42477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10614]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Training and Primary Care
Medicine and Dentistry
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Training in Primary
Care Medicine and Dentistry (ACTPCMD or Committee) will hold public
meetings for the 2024 calendar year (CY). This notice supersedes the
information about ACTPCMD's 2024 meetings found in the Federal Register
notice dated December 15, 2023, Meeting of the Advisory Committee on
Training and Primary Care Medicine and Dentistry.
DATES: ACTPCMD meetings will be held on:
August 1, 2024, 8:00 a.m.-5:00 p.m. Eastern Time and
August 2, 2024, 8:00 a.m.-3:00 p.m. Eastern Time, and
Another 2024 meeting will be identified at a later date
and announced at least 30 days before the meeting date through the
Federal Register.
ADDRESSES: Meetings will be held in-person, by teleconference, and/or
on a video conference platform. In-person meetings will be held at the
HRSA Headquarters located at 5600 Fishers Lane, Rockville, Maryland,
20857 and will also be broadcast virtually on a video conference
platform. For updates on how the meetings will be held, visit the
ACTPCMD website 20 days before the date of the meeting, where
instructions for joining meetings will be posted. For meeting
information updates, go to the ACTPCMD website meeting page at https://www.hrsa.gov/advisory-committees/primarycare-dentist/meetings.
FOR FURTHER INFORMATION CONTACT: Shane Rogers, Designated Federal
Officer, Division of Medicine and Dentistry, Bureau of Health
Workforce, HRSA, 5600 Fishers Lane, Room 15N102, Rockville, Maryland
20857; 301-443-5260; or [email protected].
SUPPLEMENTARY INFORMATION: ACTPCMD provides advice and recommendations
to the Secretary of Health and Human Services on policy, program
development, and other matters of significance concerning the
activities under Section 747 of Title VII of the Public Health Service
(PHS) Act, as it existed upon the enactment of Section 749 of the PHS
Act in 1998. ACTPCMD prepares an annual report describing the
activities of the committee, including findings and recommendations
made by the committee concerning the activities under Section 747, as
well as training programs in oral health and dentistry. The annual
report is submitted to the Secretary of Health and Human Services as
well as the Chair and ranking members of the Senate Committee on
Health, Education, Labor and Pensions and the House of Representatives
Committee on Energy and Commerce. ACTPCMD also develops, publishes, and
implements performance measures and guidelines for longitudinal
evaluations of programs authorized under title VII, part C of the PHS
Act, and recommends appropriation levels for programs under this Part.
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. For CY 2024
meetings, agenda items may include, but are not limited to, a full
review of the many programs authorized under title VII, sections 747
and 748, of the PHS Act, discussions pertaining to tribal health
issues, and potential recommendations updating the authorizing
legislations for the programs. Refer to the ACTPCMD website listed
above for all current and updated information concerning the CY 2024
ACTPCMD meetings, including agendas and meeting materials that will be
posted 20 calendar days before the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACTPCMD should be
sent to Shane Rogers using
[[Page 42477]]
the contact information above at least 5 business days before the
meeting date(s).
Individuals who need special assistance or another reasonable
accommodation should notify Shane Rogers using the contact information
listed above at least 10 business days before the meeting(s) they wish
to attend. Since all in-person meetings will occur in a federal
government building, 5600 Fishers Lane, Rockville, Maryland 20857,
attendees must go through a security check to enter the building.
Members of the public must notify the Designated Federal Officer of
their intent to attend the in-person meeting 10 business days before
the meeting. Non-U.S. Citizen attendees must notify the Designated
Federal Officer of their planned attendance at least 20 business days
prior to the meeting to facilitate their entry into the building. All
attendees are required to present government-issued identification
prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-10614 Filed 5-14-24; 8:45 am]
BILLING CODE 4165-15-P
